Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-24
2009-10-20
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S122000
Reexamination Certificate
active
07605169
ABSTRACT:
Napthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed.
REFERENCES:
patent: 5362878 (1994-11-01), Chang et al.
patent: 6403610 (2002-06-01), Malleron et al.
patent: 6602882 (2003-08-01), Davies et al.
patent: 6602884 (2003-08-01), Bacque et al.
patent: 6603005 (2003-08-01), Baque et al.
patent: 6815547 (2004-11-01), Bacque et al.
patent: 6841562 (2005-01-01), Bacque et al.
patent: 6903217 (2005-06-01), Bacque et al.
patent: 6911442 (2005-06-01), Davies et al.
patent: 6962917 (2005-11-01), Davies et al.
patent: 6989447 (2006-01-01), Markwell et al.
patent: 7001913 (2006-02-01), Davies et al.
patent: 7109213 (2006-09-01), Daines et al.
patent: 7141564 (2006-11-01), Brooks et al.
patent: 7186730 (2007-03-01), Dartois et al.
patent: 7205408 (2007-04-01), Davies et al.
patent: 7232832 (2007-06-01), Axten et al.
patent: 7232834 (2007-06-01), Bacque et al.
patent: 2005/0159411 (2005-07-01), Daines et al.
patent: 2006/0014749 (2006-01-01), Davies et al.
patent: 2006/0058287 (2006-03-01), Axten et al.
patent: 2006/0189601 (2006-08-01), Hennessy et al.
patent: 2006/0189604 (2006-08-01), Axten et al.
patent: 2007/0135422 (2007-06-01), Brooks et al.
patent: 1218370 (2004-12-01), None
patent: WO 99/37635 (1999-07-01), None
patent: WO 00/21948 (2000-04-01), None
patent: WO 00/21952 (2000-04-01), None
patent: WO 00/43383 (2000-07-01), None
patent: WO 00/78748 (2000-12-01), None
patent: WO 01/07432 (2001-02-01), None
patent: WO 01/07433 (2001-02-01), None
patent: WO 01/25227 (2001-04-01), None
patent: WO 02/08224 (2002-01-01), None
patent: WO 02/24684 (2002-03-01), None
patent: WO 02/40474 (2002-05-01), None
patent: WO 02/50040 (2002-06-01), None
patent: WO 02/50061 (2002-06-01), None
patent: WO 02/56882 (2002-07-01), None
patent: WO 02/072572 (2002-09-01), None
patent: WO 02/096907 (2002-12-01), None
patent: WO 03/010138 (2003-02-01), None
patent: WO 03/064421 (2003-08-01), None
patent: WO 03/064431 (2003-08-01), None
patent: WO 03/087098 (2003-10-01), None
patent: WO 2004/002490 (2004-01-01), None
patent: WO 2004/002992 (2004-01-01), None
patent: WO 2004/024712 (2004-03-01), None
patent: WO 2004/024713 (2004-03-01), None
patent: WO 2004/087145 (2004-10-01), None
patent: WO 2004/096982 (2004-11-01), None
Snyder et al., PubMed Abstract (J. Med. Liban 48(4): 208-214,Jul.-Aug. 2000.
Miller William Henry
Seefeld Mark Andrew
Glaxo Group Limited
Habte Kahsay T
Lemanowicz John
Willis Reid S.
LandOfFree
Antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4065413